Authors:
Leblond, V
Dhedin, N
Bruneel, MFM
Choquet, S
Hermine, O
Porcher, R
Quoc, SN
Davi, F
Charlotte, F
Dorent, R
Barrou, B
Vernant, JP
Raphael, M
Levy, V
Citation: V. Leblond et al., Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders, J CL ONCOL, 19(3), 2001, pp. 772-778
Authors:
Bosi, A
Laszlo, D
Labopin, M
Reffeirs, J
Michallet, M
Gluckman, E
Alessandrino, PE
Locatelli, F
Vernant, JP
Sierra, J
Jouet, JP
Frassoni, F
Citation: A. Bosi et al., Second allogeneic bone marrow transplantation in acute leukemia: Results of a survey by the European Cooperative Group for Blood and Marrow Transplantation, J CL ONCOL, 19(16), 2001, pp. 3675-3684
Authors:
El Kassar, N
Legouvello, S
Joseph, CM
Salesses, P
Rieux, C
Cordonnier, C
Vernant, JP
Farcet, JP
Bierling, P
Kuentz, M
Citation: N. El Kassar et al., High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs, BONE MAR TR, 27(1), 2001, pp. 35-43
Authors:
Maury, S
Jouault, H
Kuentz, M
Vernant, JP
Tulliez, M
Cordonnier, C
Bories, D
Citation: S. Maury et al., Chimerism analysis by lineage-specific fluorescent polymerase chain reaction in secondary graft failure after allogeneic stem cell transplantation, TRANSPLANT, 71(3), 2001, pp. 374-380
Citation: B. Mezzadri et Jp. Vernant, Myths and epics in Ancient Greece: Between exoticism and familiarity - Conversation with Hellenist scholar Jean-Pierre Vernant, EUR-REV LIT, 79(865), 2001, pp. 284-320
Authors:
Gahrton, G
Svensson, H
Cavo, M
Apperley, J
Bacigalupo, A
Bjorkstrand, B
Blade, J
Cornelissen, J
de Laurenzi, A
Facon, T
Ljungman, P
Michallet, M
Niederwieser, D
Powles, R
Reiffers, J
Russell, NH
Samson, D
Schaefer, UW
Schattenberg, A
Tura, S
Verdonck, LF
Vernant, JP
Willemze, R
Volin, L
Citation: G. Gahrton et al., Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres, BR J HAEM, 113(1), 2001, pp. 209-216
Authors:
Blaise, D
Maraninchi, D
Michallet, M
Reiffers, J
Jouet, JP
Milpied, N
Devergie, A
Attal, M
Sotto, JJ
Kuentz, M
Ifrah, N
Duriac, C
Bordigoni, P
Gratecos, N
Guilhot, F
Guyotat, D
Gluckman, E
Vernant, JP
Citation: D. Blaise et al., Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission, BLOOD, 97(11), 2001, pp. 3669-3671
Authors:
Fiere, D
Vernant, JP
Michallet, M
Degos, L
Leblond, V
Olteanu, N
Boucheix, C
Charrin, C
Varet, B
Huguet, FR
Delannoy, A
Gratecos, N
Lepage, E
Sebban, C
Citation: D. Fiere et al., Treatment of adult acute lymphoblastic leukemia long term results of a prospective study: LALA 87, HEMAT BLOOD, 40, 2001, pp. 389-392
Authors:
Thiebaut, A
Vernant, JP
Degos, L
Huguet, FR
Reiffers, J
Sebban, C
Lepage, E
Thomas, X
Fiere, D
Citation: A. Thiebaut et al., Adult acute lymphocytic leukemia study testing chemotherapy and autologousand allogeneic transplantation - A follow-up report of the French protocolLALA 87, HEMAT ONCOL, 14(6), 2000, pp. 1353
Authors:
Michallet, M
Thomas, X
Vernant, JP
Kuentz, M
Socie, G
Esperou-Bourdeau, H
Milpied, N
Blaise, D
Rio, B
Reiffers, J
Jouet, JP
Cahn, JY
Bourhis, JH
Lioure, B
Leporrier, M
Sotto, JJ
Souillet, G
Sutton, L
Bordigoni, P
Dreyfus, F
Tilly, H
Gratecos, N
Attal, M
Leprise, PY
Demeocq, F
Michel, G
Buzyn, A
Delmas-Marsalet, B
Bernaudin, F
Ifrah, N
Sadoun, A
Guyotat, D
Cavazzana-Cavo, M
Caillot, D
De Revel, T
Vannier, JP
Baruchel, A
Fegueux, N
Tanguy, ML
Thiebaut, A
Belhabri, A
Archimbaud, E
Citation: M. Michallet et al., Long-term outcome after allogeneic hematopoietic stem cell transplantationfor advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM), BONE MAR TR, 26(11), 2000, pp. 1157-1163
Authors:
Frassoni, F
Labopin, M
Powles, R
Mary, JY
Arcese, W
Bacigalupo, A
Bunjes, D
Gluckman, E
Ruutu, T
Schaefer, UW
Sierra, J
Vernant, JP
Willemze, R
de Witte, T
Gorin, NC
Citation: F. Frassoni et al., Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia, LANCET, 355(9213), 2000, pp. 1393-1398
Authors:
Guardiola, P
Kuentz, M
Garban, F
Blaise, D
Reiffers, J
Attal, M
Buzyn, A
Lioure, B
Bordigoni, P
Fegueux, N
Tanguy, ML
Vernant, JP
Gluckman, E
Socie, G
Citation: P. Guardiola et al., Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia, BR J HAEM, 111(1), 2000, pp. 292-302
Authors:
Michallet, M
Tanguy, ML
Socie, G
Thiebaut, A
Belhabri, A
Milpied, N
Reiffers, J
Kuentz, M
Cahn, JY
Blaise, D
Demeocq, F
Jouet, JP
Michallet, AS
Ifrah, N
Vilmer, E
Molina, L
Michel, G
Lioure, B
Cavazzana-Calvo, M
Pico, JL
Sadoun, A
Guyotat, D
Attal, M
Cure, H
Bordigoni, P
Sutton, L
Buzyn-Veil, A
Tilly, M
Leporrier, M
Fegueux, N
Dreyfus, F
Rio, B
Lutz, P
Vernant, JP
Citation: M. Michallet et al., Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM), BR J HAEM, 108(2), 2000, pp. 400-407
Authors:
Bouabdallah, R
Lefrere, F
Rose, C
Chaibi, P
Harousseau, JL
Vernant, JP
Castaigne, S
Bauduer, F
Zini, JM
Coso, D
Varet, B
Robert, J
Fenaux, P
Citation: R. Bouabdallah et al., A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients, LEUKEMIA, 13(10), 1999, pp. 1491-1496
Authors:
Gahrton, G
Svensson, H
Bjorkstrand, B
Apperley, J
Carlson, K
Cavo, M
Ferrant, A
Fouillard, L
Gratecos, N
Gratwohl, A
Guilhot, F
Deliliers, GL
Ljungman, P
Masszi, T
Milligan, DW
Powles, RL
Reiffers, J
Samson, JD
Stoppa, AM
Vernant, JP
Volin, L
Wallvik, J
Citation: G. Gahrton et al., Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation, BONE MAR TR, 24(7), 1999, pp. 741-745
Authors:
Leclercq, I
Mortreux, F
Morschhauser, F
Duthilleul, P
Desgranges, C
Gessain, A
Cavrois, M
Vernant, JP
Hermine, O
Wattel, E
Citation: I. Leclercq et al., Semiquantitative analysis of residual disease in patients treated for adult T-cell leukaemia lymphoma (ATLL), BR J HAEM, 105(3), 1999, pp. 743-751
Authors:
Hebib, NC
Deas, O
Rouleau, M
Durrbach, A
Charpentier, B
Beaujean, F
Vernant, JP
Senik, A
Citation: Nc. Hebib et al., Peripheral blood T cells generated after allogeneic bone marrow transplantation: Lower levels of Bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T-cell profiles, BLOOD, 94(5), 1999, pp. 1803-1813